InMed Pharmaceuticals Inc. (INM) reports FY EPS of ($3.25)

InMed Pharmaceuticals Inc. (NASDAQ: INM) reported FY EPS of ($3.25). Revenue for the FY came in at $4.14 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Cass Information Systems (CASS) Reports In-Line Q2 EPS
• MaxLinear (MXL) Tops Q2 EPS by 2c; Offers Guidance